SCHEMBL24951472

SCHEMBL24951472

CCOC(=O)c1cnc(C)c(NC(=O)c2cnc(Cl)nc2N(C)N)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NFKB1 P19838 6/20 0.46
▸ ATF1 P18846 5/20 0.46
▸ ALDH1A1 P00352 2/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ JUN P05412 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ MAPT P10636 3/20 0.38
▸ POLB P06746 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ JAK2 O60674 1/20 0.37
▸ JAK1 P23458 1/20 0.37
▸ TYK2 P29597 1/20 0.37
▸ JAK3 P52333 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ CA5A P35218 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30202682 0.88 ALDH1A1 (0.46) NFKB1ATF1ALDH1A1KDM4EMAPT
SCHEMBL24951831 0.88 ALDH1A1 (0.46) NFKB1ATF1ALDH1A1KDM4EMAPT
SCHEMBL30202783 0.86 WDR5 (0.47) NFKB1ATF1ALDH1A1KDM4EMAPT
SCHEMBL24951146 0.86 WDR5 (0.47) NFKB1ATF1ALDH1A1KDM4EMAPT
SCHEMBL30202755 0.86 NFKB1 (0.50) NFKB1ATF1ALDH1A1KDM4EJUN
SCHEMBL24952216 0.86 NFKB1 (0.50) NFKB1ATF1ALDH1A1KDM4EJUN
SCHEMBL30202828 0.79 JUN (0.41) NFKB1ALDH1A1KDM4EJUNNFKB2
SCHEMBL24951998 0.79 JUN (0.41) NFKB1ALDH1A1KDM4EJUNNFKB2
SCHEMBL30202695 0.75 ALDH1A1 (0.40) NFKB1ATF1ALDH1A1KDM4EJUN
SCHEMBL24952254 0.75 RAB9A (0.47) NFKB1ALDH1A1KDM4EJUNNFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023007009-A1 PYRAZOLOPYRIMIDINES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2023-02-02 — — WO disclosed
Send feedback